AR216916A1 - Procedimiento para la elaboracion de nuevas 1-ceto-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-mercapto alquil(c1-c4)-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-alcoxi-(c1-c4)-6-fenil-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas y sus sales - Google Patents
Procedimiento para la elaboracion de nuevas 1-ceto-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-mercapto alquil(c1-c4)-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-alcoxi-(c1-c4)-6-fenil-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas y sus salesInfo
- Publication number
- AR216916A1 AR216916A1 AR268053A AR26805377A AR216916A1 AR 216916 A1 AR216916 A1 AR 216916A1 AR 268053 A AR268053 A AR 268053A AR 26805377 A AR26805377 A AR 26805377A AR 216916 A1 AR216916 A1 AR 216916A1
- Authority
- AR
- Argentina
- Prior art keywords
- pirido
- fenil
- triazol
- diazepinas
- alquil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT837275A AT350056B (de) | 1975-11-04 | 1975-11-04 | Verfahren zur herstellung von neuen pyrido- (2,3-f)-(1,4)-diazepinen, deren optischen isomeren und salzen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR216916A1 true AR216916A1 (es) | 1980-02-15 |
Family
ID=3604891
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR265336A AR217814A1 (es) | 1975-11-04 | 1976-11-03 | Procedimiento para la preparacion de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)(c1,4)-diazepinas |
| AR268053A AR216916A1 (es) | 1975-11-04 | 1977-06-14 | Procedimiento para la elaboracion de nuevas 1-ceto-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-mercapto alquil(c1-c4)-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-alcoxi-(c1-c4)-6-fenil-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas y sus sales |
| AR268052A AR216915A1 (es) | 1975-11-04 | 1977-06-14 | Procedimiento para la preparacion de 1-ceto-6(2-halofenil)-8-halo-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas-2-sustituidas |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR265336A AR217814A1 (es) | 1975-11-04 | 1976-11-03 | Procedimiento para la preparacion de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)(c1,4)-diazepinas |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR268052A AR216915A1 (es) | 1975-11-04 | 1977-06-14 | Procedimiento para la preparacion de 1-ceto-6(2-halofenil)-8-halo-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas-2-sustituidas |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US4110455A (es) |
| JP (1) | JPS5831351B2 (es) |
| AR (3) | AR217814A1 (es) |
| AT (1) | AT350056B (es) |
| AU (1) | AU504228B2 (es) |
| BE (1) | BE847952A (es) |
| CA (1) | CA1076111A (es) |
| CH (1) | CH630920A5 (es) |
| CS (1) | CS191181B2 (es) |
| DD (1) | DD128178A5 (es) |
| DE (1) | DE2649116A1 (es) |
| DK (1) | DK142324B (es) |
| EG (1) | EG12280A (es) |
| ES (2) | ES452971A1 (es) |
| FI (1) | FI62088C (es) |
| FR (1) | FR2330404A1 (es) |
| GB (1) | GB1562800A (es) |
| HU (1) | HU177422B (es) |
| IL (1) | IL50816A (es) |
| IN (1) | IN144289B (es) |
| MX (1) | MX4284E (es) |
| NL (1) | NL7612187A (es) |
| NO (1) | NO146470C (es) |
| PL (2) | PL118308B1 (es) |
| PT (1) | PT65787B (es) |
| RO (2) | RO77294A (es) |
| SE (1) | SE7612260L (es) |
| SU (2) | SU667137A3 (es) |
| YU (1) | YU269176A (es) |
| ZA (1) | ZA766620B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1185601A (en) * | 1981-02-27 | 1985-04-16 | Walter Hunkeler | Imidazodiazepines |
| DE3435973A1 (de) * | 1984-10-01 | 1986-04-10 | Boehringer Ingelheim KG, 6507 Ingelheim | Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung |
| US4798896A (en) * | 1988-01-19 | 1989-01-17 | American Home Products Corporation | Antipsychotic gamma-carboline N-oxides |
| US8541407B2 (en) | 2010-03-31 | 2013-09-24 | Arqule, Inc. | Substituted benzo-pyrido-triazolo-diazepine compounds |
| AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| US9249161B2 (en) | 2010-12-02 | 2016-02-02 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| EP2705039B1 (en) | 2011-05-04 | 2017-07-26 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| EP2721031B1 (en) | 2011-06-17 | 2016-01-20 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| WO2013184878A1 (en) | 2012-06-06 | 2013-12-12 | Constellation Pharmaceuticals, Inc. | Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof |
| TWI602820B (zh) | 2012-06-06 | 2017-10-21 | 星宿藥物公司 | 溴域抑制劑及其用途 |
| DK3157928T3 (da) | 2014-06-20 | 2019-05-20 | Constellation Pharmaceuticals Inc | Krystallinske former af 2-((4s)-6-(4-chlorphenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT327917B (de) * | 1973-04-12 | 1976-02-25 | Degussa | Verfahren zur herstellung von neuen 5-aryl-pyrido- (b-6,7) -1,4-diazepinen und deren salzen |
| US4039551A (en) * | 1976-03-15 | 1977-08-02 | The Upjohn Company | 1-[(Hydroxyamino)methyl]-6-aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines |
-
1975
- 1975-11-04 AT AT837275A patent/AT350056B/de not_active IP Right Cessation
-
1976
- 1976-06-02 RO RO7697708A patent/RO77294A/ro unknown
- 1976-10-26 US US05/735,894 patent/US4110455A/en not_active Expired - Lifetime
- 1976-10-26 SU SU762414098A patent/SU667137A3/ru active
- 1976-10-27 FR FR7632326A patent/FR2330404A1/fr active Granted
- 1976-10-28 DE DE19762649116 patent/DE2649116A1/de not_active Withdrawn
- 1976-11-02 GB GB45476/76A patent/GB1562800A/en not_active Expired
- 1976-11-02 DD DD7600195560A patent/DD128178A5/xx unknown
- 1976-11-02 EG EG76673A patent/EG12280A/xx active
- 1976-11-02 YU YU02691/76A patent/YU269176A/xx unknown
- 1976-11-02 IL IL50816A patent/IL50816A/xx unknown
- 1976-11-03 SE SE7612260A patent/SE7612260L/xx not_active Application Discontinuation
- 1976-11-03 AR AR265336A patent/AR217814A1/es active
- 1976-11-03 MX MX765041U patent/MX4284E/es unknown
- 1976-11-03 PL PL1976223070A patent/PL118308B1/pl unknown
- 1976-11-03 ES ES452971A patent/ES452971A1/es not_active Expired
- 1976-11-03 HU HU76DE927A patent/HU177422B/hu unknown
- 1976-11-03 NL NL7612187A patent/NL7612187A/xx not_active Application Discontinuation
- 1976-11-03 ES ES452969A patent/ES452969A1/es not_active Expired
- 1976-11-03 NO NO763739A patent/NO146470C/no unknown
- 1976-11-03 RO RO7688309A patent/RO70245A/ro unknown
- 1976-11-03 BE BE6045743A patent/BE847952A/xx unknown
- 1976-11-03 PT PT65787A patent/PT65787B/pt unknown
- 1976-11-03 FI FI763158A patent/FI62088C/fi not_active IP Right Cessation
- 1976-11-03 PL PL1976193439A patent/PL113803B1/pl unknown
- 1976-11-03 CH CH1386976A patent/CH630920A5/de not_active IP Right Cessation
- 1976-11-03 CS CS767096A patent/CS191181B2/cs unknown
- 1976-11-03 DK DK497076AA patent/DK142324B/da not_active IP Right Cessation
- 1976-11-04 JP JP51132728A patent/JPS5831351B2/ja not_active Expired
- 1976-11-04 CA CA264,849A patent/CA1076111A/en not_active Expired
- 1976-11-04 AU AU19311/76A patent/AU504228B2/en not_active Expired
- 1976-11-04 ZA ZA766620A patent/ZA766620B/xx unknown
- 1976-11-17 IN IN2062/CAL/76A patent/IN144289B/en unknown
-
1977
- 1977-06-14 AR AR268053A patent/AR216916A1/es active
- 1977-06-14 AR AR268052A patent/AR216915A1/es active
- 1977-10-17 SU SU772532701A patent/SU676165A3/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR228444A1 (es) | Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales | |
| AR220686A1 (es) | Procedimiento para obtener derivados de 2 amino-2-desoxi-3-o-(propilcarbamoilmetil)-carbamoilmetil-glucopiranosa y sus sales | |
| MX4717E (es) | Procedimiento para la preparacion de derivados de pirrolidina | |
| AR224495A1 (es) | Procedimiento para la preparacion de derivados de 1-fenil-7,8-dihidroxi o 7,8-dialcanoiloxi-1,3,4,5-tetrahidro-1h-3-benzazepina y sus sales | |
| MX4488E (es) | Procedimiento para la preparacion de derivados de quinazolona | |
| AR229103A1 (es) | Procedimiento para la preparacion de derivados de 3-aril-5-isotiazol y sus sales | |
| AR222290A1 (es) | Procedimiento para obtener derivados de 5-het'-metil-2-het-metiltio-etilamino o 2-het-butilamino pirimidin-4-ona | |
| AR227882A1 (es) | Procedimiento para la preparacion de nuevos derivados de pirido(1,2-a)pirimidina y sus sales | |
| AR213736A1 (es) | Procedimiento para la preparacion de(2-(3 o 4)-alcoxi-2-piridil-(metiltio o etil)etil)-(ciano-guanidina o alquilaminonitroetileno) | |
| AR211887A1 (es) | Procedimiento para la preparacion de derivados de endolizina | |
| AR228144A1 (es) | Procedimiento para obtener derivados de 5-fenil-triazolidina-2,4-diona y sus sales | |
| AR216916A1 (es) | Procedimiento para la elaboracion de nuevas 1-ceto-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-mercapto alquil(c1-c4)-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-alcoxi-(c1-c4)-6-fenil-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas y sus sales | |
| AR228586A1 (es) | Procedimiento para preparar derivados de 2,3-dihidrobenzofuran-2-ona o croman-2-ona y sus sales farmaceuticamente aceptables | |
| MX3636E (es) | Procedimiento para la preparacion de propargil-2-fenilamino-imidazolinas-(2) | |
| AR231539A1 (es) | Procedimiento para la elaboracion de nuevos derivados de la curamina o del 4n-1-benzopirano y sus sales | |
| MX4796E (es) | Procedimiento para la preparacion de derivados de 2-iminotiazolina | |
| AR213184A1 (es) | Procedimiento para preparar derivados de 1,4-etan-6-oxo-perhidroquinoleina y sus sales | |
| AR225889A1 (es) | Procedimiento para la elaboracion de acidos heterociclilcarboxilicos acilados | |
| AR215851A1 (es) | Procedimiento para la preparacion de 12,13-desepoxi-12,13-dehidrorosaramicina y derivados de la misma | |
| AR208361A1 (es) | Procedimiento para la preparacion de derivados l-piroglutamil-l-histidil-3-alquil-prolinamida | |
| AR217664A1 (es) | Procedimiento para la preparacion de derivados de oleandomicina | |
| MX143905A (es) | Procedimiento para la preparacion de sales de 4-amino bencendiazonio | |
| AR211546A1 (es) | Procedimiento para la produccion de nuevas 2-fenilimino-tiazolinas substituidas y sus sales | |
| MX3845E (es) | Procedimiento para la preparacion de sulfoximidas substituidas y sus sales | |
| MX4485E (es) | Procedimiento para la preparacion de 2,4-diamino-5-bencil-pirimidinas y sus sales |